This page contains exclusive content for the member of the following sections: TTS. Log in to view.
Presenter: Joshua, Waldman, Toledo, United States
Authors: Waldman J., Rees M.
LATE BREAKING I
J.P. Waldman1, M. Rees2
1Urology, e University of Toledo Medical College of Medicine, Toledo/OH/UNITED STATES OF AMERICA, 2Urology, UNIV TOLEDO MED CENTER, TOLEDO/OH/UNITED STATES OF AMERICA
Body: Introduction: Patients in fulminate hepatic failure (FHF) currently do not have a temporary means of support while awaiting a liver transplant. In contrast, patients with end stage kidney disease can live for years on dialysis. A potential therapeutic approach for patients with FHF is the use of extracorporeal liver perfusion (ECLP) with porcine livers as a form of “liver dialysis.” During a 72 hour extracorporeal perfusion of porcine livers with human blood, porcine Kupffer cells bind to and phagocytose human red blood cells (hRBCs) causing the hematocrit to decrease to 2.5% of the original value. Our laboratory has identified N-acetylneuraminic acid (Neu5Ac) on human RBCs as the ligand being bound and sialoadhesin on porcine Kupffer cells as the lectin receptor. Before allowing clinical trials of porcine liver ECLP, the FDA is requiring additional preclinical data in which primates with FHF are successfully supported using porcine liver ECLP (personal communication, FDA Xenoadvisory Committee meeting, 2009). Given that primate other than humans express minimal amounts of Neu5Ac, we evaluated whether porcine macrophages bound the RBC from several species of Old World Primates. Methods: The ability of porcine macrophages to bind human erythrocytes was quantified using a binding assay. Herein, porcine alveolar macrophages (PAM) adhered to a well in a 96-well plate and tested for their ability to bind human and nonhuman primate erythrocytes. PAM were used as a more readily accessible Kupffer cell-like macrophage source. Results: We have shown that 1) pretreatment of PAM with antibodies specific for porcine sialoadhesin inhibits PAM binding of human erythrocytes; 2) PAM bind nonhuman primate RBCs significantly less than they bind human RBCs (p < 0.001, see Table that shows binding as a percent of human RBC binding to PAM).
RBC Species | Isotype Control mAb | a-sialoadhesin mAb | vs. human p-value |
Human | 100 + 13 | 12 + 9 | |
Baboon | 9 + 2 | 7 + 4 | 0.001 |
Gibbon | 17 + 5 | 10 + 2 | 0.0005 |
DeBrazza | 16+ 8 | 6 + 4 | 0.0003 |
Disclosure: All authors have declared no conflicts of interest.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada